Celgene Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (78)

Latest Posts

About This Stock More About This Stock
Celgene Slides After FDA Refuses Filing For Potential Multiple Sclerosis Drug
Article By: The Fly
Wednesday, February 28, 2018 2:21 PM EDT
Shares of Celgene are sliding after the company announced that it has received a Refusal to File letter from the Food and Drug Administration regarding its New Drug Application for ozanimod.
In this article: CELG
Sluggish Tape And Possibly An End To Celgene Woes?
Article By: Rod Raynovich
Wednesday, February 28, 2018 2:05 PM EDT
Biotech stocks were weak again today exacerbated by still more bad news from Celgene down over 8% on news that the FDA refused to review their Ozanimod product for relapsing Multiple Sclerosis.
In this article: CELG
SunTrust Downgrades Celgene On Refusal To File Letter For Ozanimod
Article By: The Fly
Wednesday, February 28, 2018 7:04 AM EDT
SunTrust analyst Yatin Suneja downgraded Celgene to Hold from Buy after the company received a refusal to file letter from the FDA on ozanimod for relapsing forms of multiple sclerosis.
In this article: CELG
4 Biotech Stocks That Are Potentially Setting A Major Double Top
Article By: Taki Tsaklanos
Saturday, February 24, 2018 5:20 PM EDT
The following four leading biotech stocks have shown signs of fatigue and look set for mid-term bearish outlook unless a very strong buy signal would emerge in the very short term.
In this article: ILMN, REGN, BIIB, CELG
OTEZLA (Apremilast) Phase III Data Showed Significant Improvements In Patients With Active Behçet’s Disease With Oral Ulcers
Article By: Business Wire
Saturday, February 17, 2018 4:15 PM EDT
Trial demonstrated statistically significant reductions in oral ulcers with apremilast 30mg versus placebo through week 12. Significant improvements in key secondary endpoints, including oral ulcer pain, overall disease activity and quality of life.
In this article: CELG


Latest Tweets for $CELG

No tweets yet!


Celgene Corporation Offers Compelling Growth Opportunity: Wedgewood
Jimmy Richards 1/31/2018 7:36:17 PM

Thanks 63 hedge funds invest in $CELG, 12 phase III programs and $100 Billion in free cash flow over the next 10 years! Stellar!

1 to 1 of 1 comments